Druces has welcomed Nigel Gordon as a partner in its corporate and commercial team. Bringing over three decades of experience advising high-growth businesses, Nigel strengthens the firm's expertise in Capital Markets and Mergers & Acquisitions.
Nigel has been a key player in the AIM Market since its inception in 1995, providing strategic guidance to listed and soon-to-be-listed companies. His deal experience includes advising Pan African Resources on multiple transactions, as well as the IPOs and fundraisings of life sciences companies like Synairgen and Tissue Regenix.
‘I am delighted to be joining Druces and adding to its well-regarded ECM and M&A team,’ Nigel said of his new role.
Edward Gordon Hall, CEO of Druces, expressed enthusiasm for the appointment: ‘Nigel’s impressive track record and specialist expertise in Capital Markets and M&A further strengthens the depth and capabilities of our Corporate and Commercial team. We are delighted to welcome him.’
